1. Home
  2. BROS vs CORT Comparison

BROS vs CORT Comparison

Compare BROS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dutch Bros Inc.

BROS

Dutch Bros Inc.

N/A

Current Price

$41.88

Market Cap

8.5B

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$111.51

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BROS
CORT
Founded
1992
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
9.7B
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
BROS
CORT
Price
$41.88
$111.51
Analyst Decision
Strong Buy
Buy
Analyst Count
20
5
Target Price
$76.40
$96.50
AVG Volume (30 Days)
3.7M
767.6K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
88.24
N/A
EPS
0.41
0.09
Revenue
$1,638,159,000.00
$761,407,000.00
Revenue This Year
$27.34
$26.08
Revenue Next Year
$23.01
$26.98
P/E Ratio
$102.71
$1,231.33
Revenue Growth
27.88
12.79
52 Week Low
$43.29
$28.66
52 Week High
$74.02
$126.38

Technical Indicators

Market Signals
Indicator
BROS
CORT
Relative Strength Index (RSI) 26.89 47.35
Support Level N/A $108.25
Resistance Level $59.07 $124.30
Average True Range (ATR) 1.76 4.80
MACD -0.10 -1.29
Stochastic Oscillator 2.21 16.70

Price Performance

Historical Comparison
BROS
CORT

About BROS Dutch Bros Inc.

Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies, and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company-operated shops.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: